in this issue
People & Business :: People/Executives
Ashland CEO to Have Surgery, Return to Full Duty in 2-3 Months
6:48 AM MDT | March 17, 2011 | Robert Westervelt
Ashland says that its chairman and CEO James J. O'Brien will undergo surgery to repair a perforated colon resulting from diverticulitis, and is expected to return to full duties in two to three months. O'Brien will be available on a limited basis during the recovery period. Ashland's chairman duties will be assumed Barry Perry, lead independent director and former chairman and CEO of Engelhard, during O'Brien's recovery. O’Brien’s executive duties will be assumed jointly by Lamar Chambers, Ashland's senior v.p. and CFO, and David L. Hausrath...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee